Working… Menu
Trial record 1 of 1 for:    QHD01
Previous Study | Return to List | Next Study

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02553343
Recruitment Status : Completed
First Posted : September 17, 2015
Last Update Posted : February 9, 2018
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 4, 2016
Actual Study Completion Date : April 4, 2016
Certification/Extension First Submitted : April 25, 2017